Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Recruiting Observational Study
Brain Tumor, Recurrent Brain Tumor Brain Tumor, Primary Brain Tumor - Metastatic Brain Tumor, Adult: Glioblastoma Brain Tumor, Adult Meningioma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
600 (estimated)
Sponsor
GT Medical Technologies, Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles. 2. Willing and able to provide informed consent and to participate in all evaluations. Exclusion Criteria: 1. Inability to undergo pre-operative and post-operative imagin…
Contacts

Michael A. Garcia, MD, MS

(833) 662-0044

mgarcia@gtmedtech.com

CONTACT

Sita Patel, PhD, PharmD

(833)662-0044

spatel@gtmedtech.com

CONTACT